This is the authors' abstract. We don't add key points for this paper.
Brain tumors are serious neurological abnormalities that require accurate identification and timely clinical evaluation. Magnetic Resonance Imaging (MRI) is widely used to visualize brain structures and detect abnormal tissue. However, manual examination of MRI scans requires expertise and may be time-consuming when large numbers of images must be reviewed. This paper presents a brain tumor classification approach using Convolutional Neural Networks (CNNs) and medical imaging. The implemented training pipeline uses MobileNetV2, a lightweight convolutional architecture, with transfer learning to classify MRI images into four categories: glioma, meningioma, pituitary tumor, and no tumor. The dataset contains 3,264 MRI images, including 2,870 training images and 394 testing images. Image resizing, normalization, and data augmentation are employed during preprocessing. The model is trained using the Adam optimizer and categorical cross-entropy loss for ten epochs. The recorded final training accuracy is 92.41%, while validation accuracy reaches 72.59%. A separate Flask-based application provides image-upload and classification functionality through a vision-language API. The results demonstrate the feasibility of CNN-based MRI classification while identifying limitations related to generalization and deployment consistency. The system is intended as a research prototype rather than a substitute for clinical diagnosis.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
T et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: